Related Experiment Video
Updated: Jan 31, 2026

10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
33.4K
[Pharmacokinetic Problems with Psychotropic Drug Combination Therapy]
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica
|January 9, 2019
Summary
Drug pharmacokinetics differ between patients and can change over time, especially with drug interactions. Combining multiple medications, particularly psychotropic drugs, complicates effects and is not recommended due to pharmacokinetic variability.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Drug Metabolism
Background:
- Patient-specific pharmacokinetics significantly influence drug efficacy and safety.
- Drug interactions are a common cause of pharmacokinetic variability within individuals.
- Psychotropic medications exhibit complex pharmacokinetic profiles, affecting co-administered drugs.
Purpose of the Study:
- To highlight the pharmacokinetic variability of drugs in patients.
- To explain how drug interactions, particularly with psychotropic drugs, alter drug levels.
- To advise against multidrug combination therapy based on pharmacokinetic principles.
Main Methods:
- Review of pharmacokinetic principles related to drug interactions.
- Analysis of psychotropic drug interactions involving plasma protein binding and enzyme metabolism.
- Assessment of the complexity introduced by polypharmacy.
Main Results:
- Psychotropic drugs can increase or decrease blood levels of concomitant medications.
- High plasma protein binding of psychotropic drugs can potentiate other drug effects.
- Increased number of drugs leads to more complex and unpredictable pharmacokinetic interactions.
Conclusions:
- Multidrug combination therapy presents significant pharmacokinetic challenges.
- Predicting clinical effects in polypharmacy is difficult due to complex drug interactions.
- Pharmacokinetic considerations advise against routine multidrug combination therapy.
Related Concept Videos
Pharmacokinetics: Drug–Drug Interactions
436
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
436
Drug Therapy
294
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
294
Combination Therapies and Personalized Medicine
6.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.1K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
245
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
245
Pharmacokinetics in Pediatric Patients: Drug Excretion
259
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution
304
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304

